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Abstract
We have used different mouse strains to examine In vivo and In vitro responses to the 18 kDa
protein of Mycobacterium leprae, which appears to be strongly Immunogenlc In both mice and
humans. B and T cell stimulatory epitopes recognised by different strains of mice have been
mapped using overlapping peptldes that span the entire 18 kDa protein. Previous work
established that Immunization of mice with the 18 kDa protein results in specific antibody
production to common B cell epitopes and immunization of mice with peptldes containing these
B cell epitopes resulted In the induction of specific IgG to only a limited subset of epitopes in
each strain. Now we report that T cells purified from mice Immunized with peptides that
stimulate antibody production, proliferate In vitro when rechallenged. The proliferating T cells
produce levels of IL-2 and IFN-7, that Indicate antigen-specific T helper type 1 cells are present
in significant numbers. Thus, a comparison of In vivo and In vitro data suggests that T cells
bearing the phenotype associated with potentially protective cell-mediated responses can be
primed In vivo by epitopes on small peptldes. Since T cells from both strains of mice are capable
of responding to the immunogenic synthetic peptldes In vitro, but give different responses to the
same peptldes In vivo, factors other than epltope structure appear to Influence T cell subset
activation. This may have Important Implications for diseases such as leprosy where a polarized
T cell response appears to develop and for the development of synthetic subunlt vaccines.
Introduction
A current approach to the problem of developing new generation
vaccines is to identify dominant epitopes contained within major
protein antigens of the infectious agent (1). This method has been
particularly informative for research into leprosy, a chronic
infectious disease caused by the obligate intracellular parasite
Mycobacterium leprae (2), since viable laboratory models do not
exist (3). The availability of genomic libraries of M. leprae DNA
(4), and of a range of mAbs that bind antigens from lysates of
whole M. leprae (5) has enabled the cloning of a number of genes
that encode protein antigens defined by the immune response
to M. leprae (6,7).
In this paper we discuss T cell responses to defined antigenic
epitopes of the 18 kDa protein of M. leprae, which appears to
be a significant factor in human immune responses to M. leprae
infection. Crude lysates of recombinant expression vectors
producing this protein have been shown to stimulate human T
cell clones specific for M. leprae (8). Lymphocytes from a large
proportion of leprosy contacts also proliferate in response to an
18 kDa fusion protein (9) and some M. fep/ae-specific human
T cell clones respond to a synthetic peptide duplicating part of
the amino acid sequence of the 18 kDa protein (10). We have
previously used antibody responses to synthetic peptides
spanning the 18 kDa protein to identify B cell epitopes (11,12).
We reasoned that if a peptide contained both B and T cell
epitopes, immunization of mice with such a peptide should elicit
antibody responses and provide an in vivo assay for the activation
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of T cell help. T helper (T^ cell epitopes identified by this
method in B10.BR mice and BALB/cJ mice showed considerable
strain-specific variation (12).
T cell proliferation and cytokine ELISA assays have been used
to examine the phenotype of responding T cells from both strains
of mice to the 18 kDa protein or to peptides. T cell populations
purified from mice immunized with 18 kDa protein or peptides
recognise and respond in vitro to epitopes on many of the 20-mer
peptides and these responding T cells appear to exhibit a
predominantly Th1 phenotype. In particular, T cells from both
strains of mice respond in vitro to epitopes located on peptides
1 - 20, 16 - 35, 31 - 50, and 61 - 80, which we have previously
shown each contains an epitope that only stimulates T cell
antibody help in B10.BR mice (12).
It is now well established that the class of Th cell which is
preferentially activated can determine whether protective
immunity develops in response to immunization with a defined
antigen (13,14). It has also been shown that the same antigen
can induce a dominant Th1 response under some
circumstances, but a Th2 dominated response under others
(15). Furthermore, there is increasing evidence that antigen-
specific expansion of T cell subsets may mediate the
development of pathology in leprosy (16). The data presented
in this paper also show that the ability to prime for a proliferative
response in vitro is not sufficient to predict immunogenicity in vivo.
This means that knowledge of the phenotype of responding
T cells is as important as the identity of T cell stimulatory epitopes
when considering the construction of synthetic subunit vaccines.
Methods
Animals
All strains of mice were obtained as breeding pairs from the
Jackson Laboratory (Bar Harbor, ME) and maintained as inbred
strains in the Department of Molecular Medicine at Auckland
University, New Zealand. Mice were used in experiments at
6 - 1 0 weeks of age. F, hybrid mice were bred at Auckland
University.
Preparation of antigen
The recombinant plasmid pML-3, which contains the gene for
the 18 kDa protein of M. leprae, was used to transform the
Escherichia coli strain DH5a (6). Cells were grown to late log
phase, harvested by centrifugation, and the 18 kDa protein
extracted and purified as detailed elsewhere (6,7). The purified
18 kDa protein was checked by polyacrylamide gel electro-
phoresis and was consistently of greater than 95% purity.
Ten overlapping peptides which spanned the entire 18 kDa
protein were synthesized by solid phase techniques (17) and then
purified by reverse phase high performance liquid chromato-
graphy. These were residues 1-20, 16 - 35, 31 - 50, 46 - 65,
61 - 8 0 , 76-95, 91-110, 106-125, 121-140, and 136-148.
Lyophilized, irradiated M. leprae, derived from infected
armadillos, was supplied by Dr P. Brennan (Colorado State
University, Fort Collins, CO) and M. tuberculosis from the National
Tuberculosis Reference Laboratory (Greenlane Hospital,
Auckland, New Zealand). All mycobacteria were stored in dry
form under sterile conditions at 4°C until used as an antigen for
immunization or in assays.
Immunization
Antigens were prepared by dissolving lyophilized antigen in PBS,
(150 mM NaCI, 2 mM NaH2PO4, 20 mM Na2HPO4, pH 7.2) or
in 0.1% acetic acid, if insoluble in PBS. The protocols used to
stimulate antibody production and to detect responses by ELISA
have been described previously (12).
To obtain populations of primed T cells, immunizations were
given in 100 y\ of 50% Freund's incomplete adjuvant emulsified
with 50% PBS. A volume of 25 /J of this emulsion was injected
into each of the hind footpads of the mouse and 50 iA was injected
at the base of the tail. Draining (popliteal and para-aortic) lymph
nodes were removed 7 -14 days after final immunization and
restimulated in vitro. Control animals received the same volume
of saline emulsified with Freund's incomplete adjuvant.
T cell proliferation assays
Mice were sacrificed 7 -14 days after immunization and the
popliteal and para-aortic lymph nodes removed into BSS plus
10% FCS on ice. Adherent fat was removed from the lymph
nodes and single lymph node cell suspensions were prepared
by forcing the lymph nodes through a fine mesh stainless steel
sieve. T cell populations derived from the lymph nodes were
enriched by passage over nylon wool, using a modification of
the technique of Julius etal. (18). Briefly, the eluted cells were
subjected to two cycles of column purification. The recovery of
T cells was typically 15 - 20% from lymph node, and the eluted
cells contained less than 1% B220+ and Mac-1 + cells as
determined by FACS analysis. Purified T cells did not proliferate
significantly in the presence of the immunizing antigen unless
exogenous antigen presenting cells (APCs) were added to the
culture (data not shown). The T cells were resuspended in
complete Dulbecco's modified Eagle's medium (DMEM; Gibco,
Grand Island, NY, including 2 mM glutamine, 100 U/ml each of
penicillin 6-potassium and streptomycin sulfate, 10% FCS, and
50 fM 2-mercaptoethanol) plus 5 ng/ml IL-1 at a concentration
of 2x106 cells/ml. Aliquots (100 /J) of T cell suspension were
dispensed into 96-well flat-bottomed plates containing 100 /tl of
medium with antigen titrated over the range of 0 -100 /ig/ml and
104 bone marrow-derived macrophages as a source of APCs.
Cultures were incubated at 37°C in 10% CO2 for 4 days, before
the addition of 10 iA of [3H]thymidine (New England Nuclear,
Boston, MA) containing 0.25 /iCi, to each well, and a further 8 h
incubation. Plates were then harvested onto glass-fibre filter paper
(Whatman, Maidstone, UK) and proliferation was assessed by
[3H]thymidine incorporation, determined in a scintillation counter
(Beckman model LS 8000, Fullerton, CA).
Phenotype of responding cells
CD4+ or CD8+ cells were removed from cell populations by
complement-mediated lysis, using either the anti-CD4 monoclonal
antibody GK1.5 (20) or the anti-CD8 monoclonal antibody Lyt
2.2 (21) (diluted 1:50 in DMEM/10% FCS) for 30 min on ice. Cells
were washed once and resuspended with the anti-x chain mAb
MAR-18.5 (22) (diluted 1:100 in DMEM/10% FCS) of 30 minutes
on ice and rewashed. Cells were then resuspended in DMEM,
0.5% FCS, 3.3% fresh rabbit complement, and incubated at
37°C for 30 min. Cells were washed twice, viable cell numbers
determined, before use in proliferation assays.
Culture supernatants were removed at varying times from
antigen presentation assays and tested for the presence of the
cytokines IL-2, IL-3, IL-4, and IFN-7 by ELISA as previously
described (19).
Establishment of T cell lines
Long-term T cell lines were established from single cell lymph
node suspensions prepared from mice immunized with the
18 kDa protein as detailed above. Briefly, cells were cultured for
4 days with 10 pg/ml 18 kDa protein at 5 x 106 cells/ml in 1.5 ml
in 24-well culture plates. Blasts were recovered from the interface
of a Histopaque 1083 (Sigma, St Louis, MO) gradient centrifuged
at 300 g for 15 min. Blasts were washed twice with medium, and
cultured with 1x10* irradiated syngeneic spleen cells and
2 pg/ml 18 kDa protein in 1.5 ml of complete medium. T cell lines
were maintained by weekly stimulation with 10s T cells, 1 x 10s
irradiated syngeneic spleen cells, 2 ng/ml IL-2, and 2 pg/ml
18 kDa protein in 1.5 ml of complete medium.
Analysis of Tcell line cytokines by the polymerase chain reaction
(PCR)
T cell lines were harvested after 10 days stimulation with antigen
and thoroughly washed. Cells were incubated with concanavalin
A (5 /ig/ml) and PMA (50 ng/ml) at 5x 105 cells/ml in 2 ml in
24-well plates. Cells were harvested after a further 6 h and total
RNA prepared by guanidinium thiocyanate lysis, purification on
a CsCI gradient, and phenol - chloroform extraction as previously
described (23). The recovered RNA was resuspended at
1 /tg/13 pi in diethyl pyrocarbonate treated distilled, deionized
water. cDNA synthesis was performed using 1 pg of RNA in a
total volume of 20 pi containing 10 mM Tris- HCI, 8 mM MgCI2,
50 mM KCI, 0.01% gelatin, 500 pM each dNTP, 1 mM
dithiothreitol, and 20 U AMV reverse transcriptase (Promega,
Madison, Wl). The mixture was incubated at room temperature
for 10 min, then 50 min at 45°C. The reaction was stopped at
90°C for 5 min and quenched on ice. RNAse H was added (5 U),
the mix incubated for a further 20 minutes at 37°C, and then
diluted to 100 pi. PCR reactions were performed on serial dilutions
of cDNA (from 10 ng/ml) in a final volume of 25 pi containing
10 mM Tris-HCI, 2 mM MgCI2, 50 mM KCI, 0.01% gelatin,
200 pM each dNTP, 1 pM each primer, 1 mM dithiothreitol, and
1 U AMV Taq polymerase (Perkin-Elmer Cetus, Norwalk, CT).
PCR reactions were run for 60 cycles using a solid block thermal
cycler 480 (Perkin-Elmer Cetus). Then, 5 pi of each PCR reaction
was electrophoresed through a 1.5% agarose gel and visualized
with ethidium bromide to determine the size of the amplification
products. Negative control including E. coli tRNA for the cDNA
synthesis and no cDNA or no enzyme for the PCR reactions.
Positive controls for PCR reactions were plasmids containing
the appropriate gene. Each pair of primers spanned at least
one intron, allowing mRNA to be distinguished from any
contaminating genomic DNA, and were synthesized in the
Department of Molecular Medicine.
Results
Murine proliferative responses to the 18 kDa protein
To determine whether in vitro T cell proliferative responses were
subject to a similar pattern of MHC restriction as previously shown
for in vivo IgG responses to the 18 kDa protein, three strains of
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mice, C57BL/10J, BALB/cJ, and B10.BR, were immunized with
18 kDa protein and after 7 days the draining lymph nodes were
removed and T cells enriched as described in Methods. The
recovered T cells were cultured with activated macrophages, as
a source of APCs and 18 kDa protein as antigen. The proliferative
responses described in Fig. 1(A) show that T cells derived from
C57BL/10J mice immunized with the 18 kDa protein respond
less vigorously than those from BALB/cJ or B10.BR mice. Thus,
as previously observed for IgG responses to the 18 kDa protein
(12), inan/n vitro Tcell proliferative assay, B10. BRand BALB/cJ
are also high responder strains, while C57BL/10J is a low
responder (24).
Pretreatment of purified T cells with anti-CD4 antibody and
complement completely abrogated proliferation to the 18 kDa
protein, while identical treatment using anti-CD8 antibody had
little effect (Fig. 1B) showing that in all cases, responding T cells
were of the CD4+ phenotype. Inclusion of the mAb M5/114 (anti
I-Ad, anti I-Edk) at 50 pg/ml in in vitro restimulations of BALB/cJ
T cells completely abolished proliferative responses, while
inclusion of similar levels of MKD6 (anti-l-Ad) or the mAb 10-3.6
(anti I-A*) had no effect. Proliferation of T cells from B10.BR mice
was inhibited by mAb M5/114, but not MKD6 or 10.36, indicating
that in both strains the proliferative response to all the peptides
examined was I-E restricted (data not shown).
Mice were also immunized with either 18 kDa protein,
M. leprae, M. tuberculosis, or ovalbumin and then rechallenged
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Fig. 1. (A) In vitro proliferate responses to the 18 kDa protein with T
cells from 18 kDa protein-immunized BALB/cJ, B10.BR, and C57BL/10J
mice, and syngeneic APCs as described in Methods. Each point
represents the arithmetic mean of triplicate cultures. (B) Effect on T cell
proliferation to 18 kDa protein of treatment of 18 kDa protein-reactive
T cells with anti-CD4 and anti-CD8 mAbs. Each point represents the
arithmetic mean of triplicate cultures.
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Fig. 2. (A) In vitro proWerative responses of T cells from BALB/cJ and B10.BR mice immunized with the 18 kDa protein, cultured with 20-mer peptides
(at 25 /tg/ml) and syngeneic APCs as descnbed in Methods. Each point represents the arithmetic mean of triplicate cultures. Average background
(T cells plus antigen without APCs) was 400 c.p.m. or below; proliferation in culture with 10 fig/ml 18 kDa protein was -25,000 c.p.m., in both
strains. (B) In vitro proliferate responses oi T cells from BALB/cJ and B10.BR mice immunized with individual 20-mer peptides, cultured with the
18 kDa protein (at 10 /ig/ml) and syngeneic APCs as described in Methods. Average background (T cells plus antigen without APCs) was 1000
c.p.m. or beiow, in both strains. Each point represents the arithmetic mean of triplicate cultures. (C) In vitro proliferate responses of T cells from
BALB/cJ and B10.BR mice immunized with individual 20-mer peptides, cultured with the immunizing 20-mer peptide (at 25 /ig/ml) and syngeneic
APCs as described in Methods. Average background (T cells plus antigen without APCs) was 900 c.p.m or below, in both strains. Each point represents
the arithmetic mean of triplicate cultures.
with each of these antigens in vitro (data not shown). T cells from
mice immunized with the 18 kDa protein responded to rechallenge
with the 18 kDa protein, M. leprae, or M. tuberculosis in culture.
However, M. fep/ae-primed T cells did not proliferate significantly
when restimulated in culture with 18 kDa protein. T cells from
ovalbumin-immunized mice only responded when cultured with
ovalbumin. Thus, the 18 kDa protein will stimulate T cells reactive
with both M. leprae and M. tuberculosis, although responses to
this protein constituted only a fraction of the total response to
M. leprae immunization. The ability of the 18 kDa protein to
stimulate T cells that responded to M. tuberculosis was interesting,
in that it suggested that there exist cross-reactive epitopes as
yet undefined. The inability of BCG vaccination to consistently
prevent the development of leprosy (25) implies that such
crossreactive epitopes are not necessarily protective.
Mapping of T cell epitopes on the 18 kDa protein using 20-mer
peptides
Groups of BALB/cJ and B10.BR mice were immunized with either
the 18 kDa protein or 20-mer peptides. After 7 days the draining
lymph nodes were removed, T cells purified, and cultured with
exogenous macrophages and either 18 kDa protein or one of
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Fig. 3. Regions of the 18 kDa gene predicted to be optimal T cell
stimulating epitopes by the least squares algorithm (31) are outlined. The
score below each epitope reflects the predicted potential of each site,
with higher numbers reflecting a closer match to the idealized epitope.
The site predicted to be the closest match to the 'ideal' epitope is
contained within peptide 1 - 20, which stimulates proliferation in both
strains of mice tested. However, peptide 136-148, containing the majority
of the second best match, is not an effective antigen, and peptide
91 -110, which contains the third best match, is effective at priming
profrferative responses in only one strain (BALB/cJ). Those regions which
provided help for dominant antibody responses in B10.BR mice are
indicated by shaded boxes and in BALB/cJ mice, by white boxes (12).
each of the 10 overlapping synthetic 20-mer peptides. On day
4, proliferation was assessed by incorporation of [3H]thymidine.
The results presented in Fig. 2(A) show that while T cells from
both strains of mice immunized with the 18 kDa protein respond
to many of the 20-mer peptides in T cell proliferation assays, there
were differences in the magnitudes of response. T cells from
B10.BR mice responded more strongly to peptides 1-20,
31-50, and 121-140 than those from BALB/cJ mice, while
peptides 91 -110 and 106-125 stimulated greater responses
from BALB/cJ cells. Peptides 16-35, 46-65, and 76-95
elicited similar responses in cultures prepared from either strain.
It is interesting to observe that these peptides contained the
regions of the 18 kDa protein that stimulated the strongest
antibody responses in each strain (Fig. 3), suggesting that the
region of the protein which is immunodominant, varies in animals
with different MHC haplotypes.
20-mer peptides as antigens
BALB/cJ and B10.BR mice were immunized as described with
either one of the 20-mer peptides or the 18 kDa protein, T cells
purified from the draining lymph nodes after 7 days and cultured
with activated macrophages and either the 18 kDa protein or
the immunizing peptide. The results presented in Fig. 2(B) show
that both strains of mice contained populations of T cells capable
of a strong proliferate response to 18 kDa when immunized
with a number of peptides. However, the proliferative responses
stimulated by immunization with some of these peptides (such
as 1 - 2 0 in B10.BR mice or 106-125 in BALB/cJ mice) were
of significantly greater magnitude than those induced by others.
T cells reactive with these epitopes were therefore likely to
dominate early responses to an antigen that contained them.
The proliferative responses observed when T cells from mice
immunized with the 18 kDa protein were cultured in vitro with
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synthetic peptides encoding parts of the 18 kDa protein were
small in magnitude (Fig. 2A) compared to those observed for
the whole 18 kDa protein. This suggests that none of these
peptides individually contained a discrete epitope or epitopes
against which the majority of the response to the whole 18 kDa
protein was directed. Either the dominant epitopes were not
represented amongst these peptides or the response to the whole
18 kDa protein was comprised of multiple T cells with many
specificities. The relative magnitude of responses observed when
T cells from peptide-immunized mice were challenged in vitro
with the immunizing peptide, correlated with those observed for
secondary responses to the whole 18 kDa protein, indicating that
the dominant epitopes are conserved on the peptides (Fig. 2B
and C).
Phenotype of responding T cells
When T cells from peptide-immunized mice were treated with
anti-CD4 antibody and complement, before addition to culture,
proliferation was reduced to background levels, while anti-CD8
antibody had no appreciable effect (data not shown) indicating
that as with responses to the 18 kDa protein, responding T cells
were mostly of the CD4+ phenotype. To determine the nature
of CD4+ cells that proliferated in response to challenge with
protein or peptides in vitro, supernatants were taken from
proliferating cultures after 48, 60, or 72 h. Supernatants were
then assayed for the presence of IL-2, IFN-7, or IL-4, as described
in Methods. It can be seen from the data presented in Table 1
that a strong proliferative response to challenge in vitro correlated
with high levels of IFN-7 in the supernatant. In all cases, cultures
with high levels of IFN--y contained high levels of IL-2 (data not
shown). Although these supernatants were taken from cultures
which contained heterogenous mixtures of T cells, it was clear
that little IL-4 (produced by Th2 or Th0 cells) was present. This
indicates that the T cells which proliferate the response to in vitro
challenge with most 20-mer peptides were predominantly of the
Th subset. BALB/cJ and B10.BR mice do make measurable,
though low, quantities of IL-4 when immunized and challenged
with whole protein, or B10.BR when immunized and challenged
with peptide 1 - 20 (Table 1), suggesting that Th2 or Th0 cells
were primed in vivo by these antigens.
While Th1 cells are doubtlessly primed in vivo, the apparent
dominance of Th1 cells in proliferation assays may be an artifact
of the culture conditions. To test this T cell lines were developed
from 18 kDa immunized BALB/cJ or B10.BR mice. Nine T cell
lines were obtained, specific for four different peptides. All were
a/3+, CD4+, CD8~. These lines were phenotyped by semi-
quantative PCR for IL-2, IL-4, IL-10, granulocyte macrophage
colony stimulating factor (GM-CSF), IFN-7, and (as a control)
/3-actin. The results presented in Table 2 indicate that the majority
of lines did not contain IL-4 producing cells. This is consistent
with the data in Table 1, which indicated that a strongly polarized
Th1 response developed in response to in vitro rechallenge with
peptides or the 18 kDa protein. The epitopes to which the T cell
lines responded were those that stimulated the strongest
responses from unfractionated cells—T cell lines from BALB/cJ
mice responded an epitope (or epitopes) on peptide 106-125,
while T cell lines from B10.BR mice responded to epitopes on
peptides 1 - 20 and 31 - 50. There is one other interesting point,
which was that two T cell lines from BALB/cJ mice were specific
for an epitope or epitopes on peptide 46 - 65, which stimulated
678 T cell epitopes of immunodominant M. leprae protein
Table 1 . Cytokines produced by a secondary response in vitro with purified APCs
Antigen BALB/cJ B10.BR
IL-4 (ng/ml) IFN-7 (ng/ml) IL-4 (ng/ml) IFN-7 (ng/ml)
1-20
16-35
31-50
46-65
61-80
76-95
91 -110
106-125
121-140
136-148
18kDa
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
1.9 (±0.7)
939 (±20.1)
<0.5
<0.5
<0.5
<0.5
130.3i
56.8l
302.5 l
123.9 1
<0.5
284.7 (±31 6)
i (±30.8)
I (±10.6)
i (±60.2)
I (±21.8)
2.6 (±0.9)
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
<0.5
1.6 (±0.8)
248.2 (±61.0)
94.9 (±22.4)
226.1 (±48.5)
<0.5
42.0 (±13.5)
41.9 (±12.8)
42.8 (±13.7)
41.9 (±14.2)
184 2 (±38.4)
<0.5
261.9 (±58.2)
Supernatants were taken at 60 h from the culture, fresh medium added and proliferation assayed by 3H incorporation as described in Methods.
Supernatants were quantified against known recombinant IL-4 or IFN-7 standards. In all cases, a high level of IFN-7 in the supernatant correlated
with increased levels of IL-2 and IL-3 (data not shown), which is indicative that the cytokines were produced by actively proliferating Th1 cells in
both strains Values have had background (response to a non-18 kDa peptide) subtracted. Samples where cytokine was not significantly above
background are represented by '<0.5' . Values represent the means of triplicate cultures.
Table 2. Cytokines produced by T cell lines in vitro
T cell line Strain Peptide IL-2 II-3 IL-4 IFN-7 Phenotype
1 BC, 5.BC
2.BC
3.BC, 4 BC
1 BR, 5.BR
3.BR, 4.BR
BALB/cJ
BALB/cJ
BALB/cJ
B10.BR
B10.BR
46-65
106-125
106-125
31/50
1-20
Th0 or mixed Th1/Th2
Th1
Th1
Th1
Cells were taken after 6 h concanavalin A and PMA stimulation, and RNA prepared as described in Methods. PCR products were quantified
against /S-actin and plasmids containing the gene in question after 60 cycles of PCR.
an insignificant response from unfractionated cells (Table 1).
Immunization of both BALB/cJ and B10.BR mice induced
significant levels of antibody reactive with this peptide (12). It is
possible that this antibody response was largely supported by
1^2 cells which often proliferate poorly in vitro (unpublished
data) allowing Th1 cells to outgrow and dominate the long-term
cultures, while not being obvious in short-term restimulations.
Response to peptide 1-20 in BALB/cJ mice
The data presented in this and a previous paper suggest an
apparent paradox. Both B10.BR and BALB/cJ mice have B cells
that recognise an epitope, or epitopes, on peptide 1 - 20 , as
immunization with intact 18 kDa protein led to the production of
high titres of IgG that binds to this peptide (12). Immunization
of both strains of mice with peptide 1 - 20 leads to the induction
of antibody only in B10.BR, not BALB/cJ mice (12). These
findings imply that only B10.BR, not BALB/cJ mice, have T cells
capable of providing cognate help for B cell responses to
epitopes located within peptides 1 - 20. However, the data
presented in Fig. 2 and Table 1 show that purified T cells from
BALB/cJ mice immunized with either 18 kDa protein or peptide
1 - 20 recognise and respond to an epitope or epitopes
contained within peptide 1 - 2 0 .
To investigate whether the differences in the responses shown
by these mouse strains were due to different affinities of the
peptide for MHC, bone marrow-derived APCs from B10.BR and
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Fig. 4. Proliferative responses of T cells from F, (BALB/cJ xB10.BR)
mice immunized with peptide 1 - 20 cultured with 20-mer peptides at
25 /ig/ml and F, or parental APCs as described in the Methods section
Average background (T cells plus antigen without APCs) was 800 c.p.m.
or below, in both strains. Each point represents the arithmetic mean of
trinlicate cultures.
BALB/cJ mice were used to pfesent peptide 1 - 20 to T cells from
F, (BALB/cJ xB10.BR) mice, which had been immunized with
this peptide. It was found (Fig. 4) that BALB/cJ- or B10.BR-
derived macrophages, pulsed with peptide 1 - 20 before
Table 3. Antibody isotypes produced in vivo (midpoint titres)
Antigen
1-20
91-115
18 kDa
BALB/cJ
lgG1
1:100
1:1150
1:1030
lgG2a
undetectable
1:10
1:108
B10.BR
lgG1
1:1030
1:145
1:1150
lgG2a
1:100
undetectable
1:143
IgG midpoints titres to the indicated antigens from BALB/cJ and B10.BR
mce immunized muftiple times with peptides 1 - 20,91 -115, and 18 kDa
protein peptide. 91 -115 was used rather than the 20-mer 91 -110 since
the former was a more potent stimulator of antibody cross-reactive with
the whole 18 kDa protein (12). Results represent the mean of specific
antibody in sera titrated from five individuals of each strain. The isotype
specific ELISAs used antibodies for lgG1 (G1-6.5) and lgG2a (R12-4)
from Pharmingen (San Diego, CA). Immunization with these peptides
stimulated antibody production with a low proportion of lgG2a, a pattern
associated with Th2 dominated responses (24) In contrast, the ratio of
lgG1 and lgG2a is more even, when mice are immunized with the 18 kDa
protein Together with the results shown in Table 1, this suggests that
both Th1 and Th2 cells may be activated.
irradiation, and then washed to remove free antigen, stimulated
F, T cells with similar efficiency, demonstrating that BALB/cJ-
derived APCs process and present this peptide at a similar
efficiency to those derived from B10.BR mice.
The strong proliferative response observed to in vitro
rechallenge with peptide 1 - 20 by T cells derived from BALB/cJ
mice shows that cells can be effectively primed by this peptide
in vivo, but these cells do not provide help for effective antibody
production (Table 3). This appears to be due to selective
activation of Th1 cells in vivo (manuscript submitted).
Discussion
The aim of this work has been to map regions within the 18 kDa
protein that contain T cell epitopes, using an in vitro T cell
proliferative assay and to compare these with T cell epitopes
previously mapped by their ability to provide help for B cell
responses (12). This approach may give insight into the factors
governing activation of pathogenic or protective responses to
the leprosy bacillus, given that the 18 kDa protein appears to
be an important antigen in the response to M. leprae (8 -10).
In the mouse footpad model, immunization with M. habana, which
unlike the majority of mycobacteria shares the 18 kDa protein,
induced some protection against challenge with M. leprae (31),
suggesting that this protein may contain epitopes with potential
for protective immunization.
The specific epitopes which dominate an immune response
may have a major impact on the progress of disease (27), due
to the action of antigen-specific suppressor cells (28) or as a result
of the imbalance of subsets of Th cells (29). It has been
postulated that the terminal poles of leprosy, which are
characterized by either strong cell-mediated immunity or T cell
unresponsiveness, may be caused by an imbalance in Th1 and
Th2 cells, analogous to similar states studied in other disease
models (30). Characterization of the epitopes recognised by T
cells and the nature of the T cell response to dominant epitopes
is therefore of great importance.
Our results indicate that while different strains of mice see
similar B cell epitopes on the 18 kDa protein, they see different,
T cell epitopes of immunodominant M. leprae protein 679
but overlapping, sets of T cell epitopes. This implies a degree
of promiscuity in TCR- antigen -MHC interactions that could
enable the construction of composite synthetic immunogens,
recognised by divergent, or outbred populations. Moreover, the
epitopes which evoked the strongest responses (as assessed by
proliferation) in different mouse strains, are the same ones which
provided the most potent T cell help for antibody production, (12)
suggesting that the same epitopes are seen in vivo and in vitro.
The cytokines produced in vitro (Tables 1 and 2) show that Th1
cells are effectively primed by these peptides, although analysis
of the antibody isotypes suggest that Th2 responses are a
significant part of the in vivo response (Table 3).
A striking feature of the responses described here is the
difference between BALB/cJ and B10.BR mice with regard to
their responses to peptide as compared with the whole 18 kDa
protein. When T cells from BALB/cJ mice immunized and
challenged in vitro with individual peptides were assayed for
proliferation, responses were seen against those peptides which
had stimulated a response with 18 kDa-primed T cells but, in
addition, responses to peptides 1 -20 , 76-95, and 121-140
became apparent (Fig. 2). This indicates that BALB/cJ mice
possess T cells reactive with epitopes contained on these
peptides, but when immunized with the 18 kDa protein, these
T cells are not effectively primed. In contrast, B10.BR mice
respond effectively to the same peptides whether immunized with
peptide or whole protein. Given that the APCs from BALB/cJ or
B10.BR mice appear to present peptide 1 - 2 0 to F, T cells with
no significant difference in efficiency (Fig. 4), it seems unlikely
that either antigen - MHC binding, or the reaction of the TCR and
the antigen - MHC complex is in some way defective in BALB/cJ
mice. The epitopes so far defined remain unchanged across a
wide range of antigen concentrations, suggesting that T cell
activation in these strains is not influenced by minor variations
in the concentration of antigen. This leaves two likely explanations
for these data. It is possible that variation in avidity of antigen-
specific receptors in these two strains could lead to preferential
uptake of antigen by different classes of APCs. Results obtained
in our laboratory suggest that the nature of the response can
be manipulated by influencing the type of APCs which presents
to a mixed T cell population (manuscript submitted) with
subsequent bias in the development of T cell subsets. Equally,
it may be that variation in H-2 I-E molecules could lead to
activation in one strain of specific suppressor cells, as suggested
for M./eprae-specific HLA-DQ restricted human suppressor
clones (28). Alternatively, this result may reflect real differences
in the nature of the cellular populations of these mice, perhaps
developed during the selection process. The development of
systems in which antigenic epitopes have been described allows
these questions to be further addressed, since at last we are able
to analyse exactly what the effects of different immunization
strategies are on defined T cell populations in vivo. This must
help our understanding of the molecular processes involved in
T cell recognition and activation.
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